Consistent Export Growth: 11.53% CAGR Over 8 Years
India's exports under HSN Chapter 30 have grown at a compound annual rate of 11.53% over 8 fiscal years, rising from ₹1,03,239.93 Crore in FY 2018-19 to ₹2,21,612.65 Crore in FY 2025-26.
HSN Chapter 30 represents Pharmaceutical Products under GST classification. This code helps businesses identify Pharmaceutical Products correctly for billing, taxation, and trade purposes. With HSN Chapter 30, companies can avoid errors in invoices, simplify compliance, and enable hassle-free import/export of Pharmaceutical Products.
Manage correct HSN codes and GST rates with BUSY.
Following Sub Chapters fall under Pharmaceutical Products:
Sub Chapter
New GST Rate
Old GST Rate
Description
Glands and other organs for organotherapeutic uses, dried,whether or not powdered; extracts of glands or other organs or of their secretions for organotherapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included
Sub Chapter
New GST Rate
Exempt (0%) for human blood and its components, and for the 37 life-saving drugs listed in Annexure I; 5% for other biological products, vaccines and diagnostic kits. Source: Notification 10/2025-Central Tax (Rate), S. No. 113, 114 and Annexure I.
Old GST Rate
Description
Human blood; animal blood prepared fortherapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines,toxins, cultures of micro-organisms (excluding yeasts) and ether similar products; cell cultures, whether or not modified
Sub Chapter
New GST Rate
Exempt (0%) for the 37 life-saving drugs listed in Annexure I; 5% for other medicaments and natural menthol; 18% for non-natural menthol crystals. Source: Notification 10/2025-Central Tax (Rate), S. No. 113 and Annexure I.
Old GST Rate
Description
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
Sub Chapter
New GST Rate
Exempt (0%) for the 37 life-saving drugs, mostly for cancer and rare diseases, listed in Annexure I; 5% for all other medicaments. Source: Notification 10/2025-Central Tax (Rate), S. No. 113 and Annexure I.
Old GST Rate
Description
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
Sub Chapter
New GST Rate
Old GST Rate
Description
Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes
Sub Chapter
New GST Rate
Exempt (0%) for contraceptives, and for the 37 life-saving drugs listed in Annexure I; 5% for other pharmaceutical goods, including waste pharmaceuticals. Source: Notification 10/2025-Central Tax (Rate), S. No. 113, 115 and Annexure I.
Old GST Rate
Description
Pharmaceutical goods specified in note 4 to this chapter
BUSY auto-applies the correct HSN codes & GST rates, ensuring 100% error-free billing every single time.
India’s Exports
FY 2025-26₹2,21,613 Cr
5.6807% of India’s total exports
India’s Imports
FY 2025-26₹31,907 Cr
0.4653% of India’s total imports
Trade Balance
FY 2025-26₹1,89,705 Cr
Surplus rank #1 of 97 chapters
At a glance
11.53%
Export CAGR
FY 2018-19 → FY 2025-26 · 8 fiscal years
#6
National Export Rank
of 97 chapters by export value, FY 2025-26
+24.48%
Peak Growth Year
FY 2020-21 · strongest single-year move
2.1×
Export Growth · 8Y
₹1,03,239.93 Cr → ₹2,21,612.65 Cr
8-year export and import data, FY 2018-19 to FY 2025-26, in ₹ Crore. Source: Ministry of Commerce & Industry, TradeStat EIDB.
Balance
+88,658.80
Exports
1,03,239.93 ₹ Cr
4.4757% share
— YoY
Imports
14,581.13 ₹ Cr
0.4057% share
— YoY
Balance
+98,942.66
Exports
1,15,473.03 ₹ Cr
5.2051% share
+11.85% YoY
Imports
16,530.37 ₹ Cr
0.4919% share
+13.37% YoY
Balance
+1,24,804.03
Exports
1,43,738.39 ₹ Cr
6.6599% share
+24.48% YoY
Imports
18,934.36 ₹ Cr
0.6494% share
+14.54% YoY
Balance
+1,18,977.90
Exports
1,44,580.86 ₹ Cr
4.5950% share
+0.59% YoY
Imports
25,602.96 ₹ Cr
0.5599% share
+35.22% YoY
Balance
+1,38,620.82
Exports
1,59,643.65 ₹ Cr
4.4092% share
+10.42% YoY
Imports
21,022.83 ₹ Cr
0.3656% share
−17.89% YoY
Balance
+1,61,648.86
Exports
1,83,051.61 ₹ Cr
5.0592% share
+14.66% YoY
Imports
21,402.75 ₹ Cr
0.3811% share
+1.81% YoY
Balance
+1,82,904.08
Exports
2,08,128.62 ₹ Cr
5.6199% share
+13.70% YoY
Imports
25,224.54 ₹ Cr
0.4136% share
+17.86% YoY
Balance
+1,89,705.20
Exports
2,21,612.65 ₹ Cr
5.6807% share
+6.48% YoY
Imports
31,907.45 ₹ Cr
0.4653% share
+26.49% YoY
CAGR · 8-Year
Exports
11.53% /yr
Imports
11.84% /yr
India's exports under HSN Chapter 30 have grown at a compound annual rate of 11.53% over 8 fiscal years, rising from ₹1,03,239.93 Crore in FY 2018-19 to ₹2,21,612.65 Crore in FY 2025-26.
In FY 2025-26, HSN Chapter 30 ranks #6 out of 97 chapters by total export value. By trade surplus, it ranks #1 of 97.
The strongest single-year export movement for HSN Chapter 30 was recorded in FY 2020-21, when exports surged by 24.48% over the prior year.
In FY 2025-26, India's exports of ₹2,21,612.65 Cr exceeded imports of ₹31,907.45 Cr, resulting in a trade surplus of ₹1,89,705.20 Crore — ranking #1 of 97 by surplus magnitude.
India's imports under HSN Chapter 30 have grown at 11.84% CAGR, reaching ₹31,907.45 Crore in FY 2025-26.